Graphs to estimate an individualized risk of breast cancer

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 103-110

  Benichou, J ^a   Gail, M H ^a   Mulvihill, J J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030031476     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.103     Document Type: Article

References (33)

1. Boring CC, Squires TS, Tong T, et al: Cancer statistics, 1994. Ca 44:7-26, 1993
2. Mulvihill JJ, Safyer AW, Bening JK: Prevention in familial breast cancer: Counseling and prophylactic mastectomy. Prev Med 11:500-511, 1982
3. Biesecker BB, Boehnke M, Calzone K, et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970-1974, 1993
4. Committee to Advise the Department of Defense on Its Fiscal Year 1993 Breast Cancer Program: Strategies for Managing the Breast Cancer Research Program: A Report to the U.S. Army Medical Research and Development Command. Washington, DC, National Academy, 1993
5. Kelsey JL, Gammon MD: The epidemiology of breast cancer. Ca 41:146-165, 1991
6. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
7. Futreal A, Liu Q, Shattuck-Eidens D, et al: Mutations in primary breast and ovarian carcinomas. Science 266:120-122, 1994
8. Simard J, Tonin P, Durocher F, et al: Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 8:392-398, 1994
9. Friedman L, Ostermeyer EA, Szabo CI, et al: Confirmation of BRCAI by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet 8:399-404, 1994
10. Easton DF, Ford D, Bishop DT, et al: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271, 1995
11. Shattuck-Eidens D, McClure M, Simmard J, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273:535-541, 1995
12. Castilla LH, Couch FC, Erdos MR, et al: Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 8:387-391, 1994
13. Wooster R, Neuhausen S, Mangion J, et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090, 1994
14. Ottman R, Pike MC, King M-C, et al: Practical guide for estimating risk for familial breast cancer. Lancet 2:556-558, 1983
15. Ottman R, Pike MC, King M-C, et al: Familial breast cancer in a population-based series. Am J Epidemiol 123:15-21, 1986
16. Anderson DE, Badzioch MD: Risk of familial breast cancer. Cancer 56:383-387, 1985
17. Claus EB, Risch NJ, Thompson WD: Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961-972, 1990
18. Claus EB, Risch NJ, Thompson WD: Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242, 1991
19. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer 73:643-651, 1994
20. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
21. Baker LH: Breast Cancer Detection Demonstration Project: Five-year summary report. Ca 32:194-225, 1982
22. Anderson SJ, Ahnn S, Duff K: NSABP Breast Cancer Prevention Trial Risk Assessment Program, Version 2. Pittsburgh, PA, University of Pittsburgh Department of Biostatistics, August 14, 1992
23. Smigel K: Breast cancer prevention trial takes off. J Natl Cancer Inst. 84:669-670, 1992
24. Benichou J: A computer program for estimating individualized probabilities of breast cancer. Comput Biomed Res 26:373-382, 1993
25. Gail MH, Benichou J: Assessing the risk of breast cancer in individuals, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer Prevention. Philadelphia, PA, Lippincott, 1992, pp 1-15.
26. Benichou J, Gail MH: Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 51:182-194, 1995
27. Benichou J: A complete analysis of variability for estimates of absolute risk from a population-based case-control study on breast cancer. Biometric J 37:3-24, 1995
28. American Society of Human Genetics Ad Hoc Committee: Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Human Genet 55:i-iv, 1994
29. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 273:577-585, 1995
30. Gail MH, Benichou J: Validation studies on a model for breast cancer risk. J Natl Cancer Inst 86:573-575, 1994 (editorial)
31. Spiegelman D, Colditz GA, Hunter D, et al: Validation of the Gail et al model for predicting individualized breast cancer risk. J Natl Cancer Inst 86:600-607, 1994
32. Bondy ML, Lustbader ED, Halabi S, et al: Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86:620-625, 1994
33. Hanssen AMN, Fryns JP: Cowden syndrome. J Med Genet 32:117-119, 1995